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Background: The development of osteoporosis is associated with several risk factors, such as genetic
polymorphisms and enviromental factors. This study assessed the correlation between SAA1 gene rs12218
polymorphism and HDL-C lelvels and osteoporosis in a population of Chinese women.
Methods: A total of 387 postmenopausal female patients who were diagnosed with osteoporosis (case group) based
on bone mineral density measurements via dual-energy x-ray absorptiometry and 307 females with no osteoporosis
(control group) were included in this study. Correlations between SAA1 gene rs12218 polymorphism and osteoporosis
and HDL-C level were investigated through the identification of SAA1 gene rs12218 polymorphism genotypes using
the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
Results: The TT genotype of rs12218 was more frequently in osteoporosis patients than in control subjects (P <0.001).
And the rs12218 was found to be associated with plasma TG, HDL-C, LDL-C, and BMD levels in osteoporosis patients
(P<0.05).
Conclusions: The present results indicate that both osteoporosis and lipids levels are associated with the TT genotype
of rs12218 in the human SAA1 gene.
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Osteoporosis is a major public health problem with grow-
ing prevalence. Obesity and hyperlipidemia have been
demonstrated to be closely related with osteoporosis [1-3].
And osteoporosis is especially prevalent in the elderly
population, and it is a significant public health issue that
reduces patient functioning and quality of life. Moreover,
both osteoporosis and obesity have high genetic predis-
position and the genetic correlation between them have
been established across different ethnic groups [1,4].
Serum amyloid A (SAA) is a kind of apolipoprotein and is
primarily synthesized in the liver by activated monocytes
and macrophages [5]. As an apolipoprotein, SAA is associ-
ated with HDL-C and during inflammation can contribute
up to 80% of its apoprotein composition [6]. Many studies
have demonstrated that sustained high expression of SAA
may contribute to atherogenesis [7,8], and that an elevated
concentration of SAA is associated with an increased risk* Correspondence: fengzhengping_f@yeah.net
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reproduction in any medium, provided the orof CVD [9]. And serveral studies indicated rs12218 in the
SAA1 gene was associted with carotid atherosclerosis [10]
and peripheral arterial disease [11]. However, the relation-
ships between SAA gene polymorphisms and osteoporosis
remain unclear.
In the present study, we aim to study the relationship
between SAA1 gene polymorphsim (rs12218) and HDL-C
level and osteoporosis.Results and discussion
Table 1 shows the clinical characteristics of the study par-
ticipants, the following values were significantly different
between the 2 groups: systolic blood and age. There was
no significant difference in the following variables between
the 2 groups: DBP, body mass index (BMI), plasma con-
centration of total cholesterol (TC), plasma concentration
of TG, HDL-C and LDL-C.
Table 2 shows the distribution of the genotypes and al-
leles of the rs12218. The genotype distribution of each
rs12218 did not show significant difference from the
Hardy-Weinberg equilibrium values (data not shown). Ford. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Characteristics of these two groups
Control group Osteoporosis group P value
Subjects (n) 387 307
Age (years) 51.32±4.618 55.45±8.055 <0.001
BMI (kg/m2) 24.17±3.15 24.22±3.82 0.827
SBP (mmHg) 119.35±10.75 117.47±9.98 0.019
SBP (mmHg) 74.93±8.23 75.66±8.37 0.245
TG (mmol/L) 1.02±.44 1.05±.46 0.372
TC (mmol/L) 4.17±.95 4.16±.95 0.861
HDL-C (mmol/L) 1.28±.51 1.24±.40 0.365
LDL-C (mmol/L) 2.49±.73 2.54±.82 0.443
Table 3 Logistic regression analysis
B S.E. Wald df Sig. OR (95% CI)
rs12218 2.029 0.399 25.927 1 <0.001 7.610(3.484-16.620)
age 0.134 0.017 60.331 1 <0.001 1.143(0.516-1.112)
BMI 0.045 0.026 2.991 1 0.084 1.047(1.105-1.183)
SBP −0.049 0.010 25.591 1 <0.001 0.952(0.994-1.102)
DBP 0.053 0.012 20.468 1 <0.001 1.055(0.934-.970)
BUN 0.026 0.056 0.217 1 0.641 1.026(1.031-1.079)
GLU 0.044 0.189 0.055 1 0.815 1.045(0.920-1.145)
UA 0.001 0.001 1.033 1 0.309 1.001(0.721-1.515)
TG 0.078 0.207 0.143 1 0.706 1.081(0.999-1.004)
TC −0.239 0.149 2.563 1 0.109 0.787(0.721-1.621)
LDL 0.191 0.181 1.110 1 0.292 1.210(0588–1.055)
Constant −6.883 1.685 16.692 1 <0.001 0.001(.849-1.726)
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of rs12218 differed significantly between the osteoporosis
patients and the control participants (both P<0.001). The
TT genotype and T allele were more common in the osteo-
porosis patients than in the control participants. Logistic
regression was performed with and without lipid disorders
and other confounders. The TT genotype of rs12218 still
differed significantly between these two groups (P<0.001,
OR=7.610, 95% CI: 3.484-16.620, Table 3).
Table 4 shows the relationgship between rs12218 and
TG, TC, HDL-C LDL-C, and BMD levels. In the osteopor-
osis group, we found that the rs12218 was not only signifi-
cantly associated with plasma TC, HDL-C, and LDL-C
levels (P=0.021, P=0.009, and P=0.009, respectively), but
also associated with BMD (P<0.05). However, this associ-
ation was not found in the control group. And, we did not
find the TG level was significantly associated with rs12218
in these two groups. In addition, we also found the rs12218
was associated with the plasma SAA levels not only in the
case group, but also in the control group (Figure 1).
In the present study, we found that variation in the
SAA1 genes is associated with both osteoporosis and TC,
HDL, and LDL levels in osteoporosis in Chinese popula-
tion. This is the first study to observe the relationship
btween SAA1 gene and osteoporosis. Osteoporosis is char-
acterized by low bone mass, an increase in bone fragility,
deterioration in bone microarchitecture, and an increase in
the risk of fracture [12]. Some metabolic changes, such as
those that occur due to a lack of estrogen, immobilization,
metabolic acidosis, hyperparathyroidism, and systemic and
local inflammatory diseases, affect the osteoclast count and
activity associated with bone turnover [13]. Prostaglandins,
insulin-like growth factors (IGFs), interleukins (IL-1, IL-6,Table 2 Distributoion of genotypes and allels
Genotypes
CC CT TT
Osteoporosis group 46 (15.0) 79 (25.7) 182 (
Control group 9 (2.3) 128 (33.1) 250 (and IL-11), tumor necrosis factor (TNF), and several local
factors in bone, such as transforming growth factor (TGF),
also contribute to the regulation of bone formation and re-
sorption [13,14].
The gene for SAA1 was considered as a candidate for
osteoporosis because it is the gene encoding one important
inflammation factor, SAA, which is synthesized by the li-
ver. A relationship between the SAA1 gene polymorphism
and cardiovascular diseases has been reported previously
[11,12,15]. Previous studies have investigated the SAA1
rs12218 polymorphism in the Chinese population, but its
relationship with osteoporosis has not been investigated;
this relationship was examined in our study for the first
time. In the present study, the TT genotype of rs12218 sig-
nificantly differed between osteoporosis patients and con-
trol participants, indicating that the risk of osteoporosis is
increased in participants with the T allele of rs12218. Lo-
gistic regression analysis adjusted for some confounders
showed that TT genotype distribution of rs12218 signifi-
cantly differed between the osteoporosis patients and the
control participants.
In additon, we also found the rs12218 significantly associ-
ated with the plasma TC levels in the osteoporosis patients,
our finding was in line with Xie et al. reports. In the early
1970s, SAA was identified as the plasma protein respon-
sible for forming tissue deposits called “amyloid (AA-type)”
seen in diseases with underlying persistent acute inflamma-
tion [16,17]. Soon after its discovery, SAA was shown to be
an acutephase protein produced by the liver within hours
of tissue injury regardless of cause. Its plasma concentrationAllel
P value C T P value
59.3) <0.001 171 443 <0.001
64.6) 146 628
Table 4 The relationship between genotypes and TG, TC, HDL, LDL and BMD
Osteoporosis group Control group
Genotypes N (M±SD) P value N (M±SD) P value
TG (mmol/L) CC 9 0.77±.32 0.188 46 0.99±.46 0.603
CT 128 1.01±.46 79 1.06±.44
TT 250 1.04±.44 182 1.07±.47
TC(mmol/L) CC 9 3.46±1.28 0.021 46 4.17±.94 0.933
CT 128 4.07±1.03 79 4.12±.93
TT 250 4.24±.85 182 4.17±.96
HDL(mmol/L) CC 9 1.77±1.89 0.009 46 1.31±.45 0.325
CT 128 1.23±.44 79 1.26±.36
TT 250 1.28±.42 182 1.22±.41
LDL(mmol/L) CC 9 1.94±.91 0.009 46 2.58±.72 0.524
CT 128 2.40±.75 79 2.45±.76
TT 250 2.56±.71 182 2.57±.86
BMD (L1-L4) (g/cm2) CC 9 0.871±0.12 0.032 46 1.021±0.15 0.143
CT 128 0.856±0.15 79 1.142±0.14
TT 250 0.814±0.14 182 1.014±0.15
Hip BMD (g/cm2) CC 9 0.679±0.09 0.047 46 0.875±0.11 0.092
CT 128 0.653±0.11 79 0.851±0.13
TT 250 0.621±0.08 182 0.844±0.10
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SAA is associated with HDL [20,21] and, during severe in-
flammation, can contribute 80% of its apo-protein compos-
ition [22]. The displaced apoA-I is rapidly cleared by the
liver and kidneys [23], together with a sharp decline in
apoA-I gene expression during inflammation [24].
Conclusions
In conclusion, the SAA1 gene polymorphism was associ-
ated with osteoporosis in Chinese population. And thisFigure 1 The SAA concentrations between genotypes of rs12218.association maybe related to the lipid disorder resulting
from the SAA gene polymorphisms.
Methods
Subjects
Postmenopausal females who were admitted to the De-
partment of Endocrinology, First Affiliated Hospital of
Chongqing Medical University were informed of the
study, and patients who opted for inclusion in the study
were evaluated. Patients who were diagnosed with
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that affect bone metabolism; patients with a history of
malignancy or surgically induced menopause; and pa-
tients who used drugs affecting bone metabolism (e.g.
corticosteroids, anticonvulsants, and heparin) during the
clinical and laboratory assessments were excluded from
the study. Erythrocyte sedimentation rate, complete
blood count, serum alkaline phosphatase, calcium, phos-
phorous, serum glutamic oxaloacetic transaminase, se-
rum glutamic pyruvic transaminase, gamma-glutamyl
transpeptidase, blood urea nitrogen, creatinine, glucose,
uric acid, albumin, total protein, urine calcium/creatinine,
thyroid-stimulating hormone, parathyroid hormone, cortisol
and vitamin D levels were measured prior to the study. A
total of 694 patients satisfied the study criteria and were
included in the study. The age, height, weight, and body
mass index (BMI) of the participants were evaluated. All
participants underwent dual-energy xray absorptiometry
(DEXA) evaluations, and 387 postmenopausal females
were diagnosed with osteoporosis based on this
assessment (osteoporosis gorup). 307 patients without
osteoporosis were included in the control group. All par-
ticipants provided informed consent in compliance with
the study protocol, which was approved by the Ethics
Committee of the First Affiliated Hospital of Chongqing
Medical University.Bone mineral density
The participants underwent DEXA scanning using a
Hologic QDR 4500 W system (Hologic, Inc., Bedford,
USA) to assess bone mineral density (BMD), and the lum-
bar spine (vertebrae L1-L4) and hip (femur neck) were
evaluated. Patients with a mean bone density below 2.5 SD
were diagnosed with osteoporosis, as recommended by the
World Health Organization (WHO).Genotyping
Genomic DNA was extracted from peripheral blood leuko-
cytes using a DNA extraction Kit (Beijing Bioteke Com-
pany Limited, Beijing, China). Genotyping was confirmed
by polymerase chain reaction (PCR)-restriction fragment
length polymorphism (RFLP) analysis. The primers of
rs12218 were designed according to Xie’s protocol [10,11]
as follows: Sense: 50AACAGGGAGAATGGGAGGGTG
GG30; Antisense: 50 GCAGGTCGGAAGTGATTGGGGT
C30. The PCR mixture was subjected to 35 cycles for
60 sec at 94°C, 30 sec at 54°C, and 40 sec at 72°C following
the initial denaturation for 3 min at 94°C. These PCR prod-
ucts were digested by Bgl I restriction enzyme was ac-
cording to manufacturer’s instructions. To ensure the
results to be verified, we used sequenced genomic DNAs
as positive controls in our assays.Statistical analysis
The data were evaluated using SPSS Version 17 software
(IBM Corp. Armonk, New York, USA). The continuous
variables were not normally distributed based on the
Shapiro-Wilk test for normality. The Mann–Whitney U
test was implemented for the comparison of the two
groups. Medians (quartiles) are provided as descriptive sta-
tistics. The Pearson chi-square test was conducted for cat-
egorical variables. N and % values are provided. A p<0.05
was considered statistically significant.
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